Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Lifeist Wellness Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.055 |
52 Week High | CA$0.31 |
52 Week Low | CA$0.0001 |
Beta | 1.24 |
11 Month Change | 5.81% |
3 Month Change | 3.80% |
1 Year Change | -50.36% |
33 Year Change | -96.09% |
5 Year Change | -98.94% |
Change since IPO | -96.26% |
Recent News & Updates
Recent updates
Shareholder Returns
M5B0 | DE Retail Distributors | DE Market | |
---|---|---|---|
7D | 0% | -2.0% | -1.9% |
1Y | -50.4% | 10.3% | 12.3% |
Return vs Industry: M5B0 underperformed the German Retail Distributors industry which returned 10% over the past year.
Return vs Market: M5B0 underperformed the German Market which returned 12.8% over the past year.
Price Volatility
M5B0 volatility | |
---|---|
M5B0 Average Weekly Movement | 25.2% |
Retail Distributors Industry Average Movement | 4.4% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: M5B0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: M5B0's weekly volatility has decreased from 10171% to 25% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Meni Morim | www.lifeist.com |
Lifeist Wellness Inc. operates as a wellness company in North America and Australia. It operates an online marketplace for hemp-derived CBD and accessories; and a butane hash oil extraction facility. The company also distributes licensed and in-house branded adult-use cannabis and cannabis derived products; and supplies hardware, including vaporizers and related accessories, as well as engages in the biosciences and consumer wellness business.
Lifeist Wellness Inc. Fundamentals Summary
M5B0 fundamental statistics | |
---|---|
Market cap | €2.17m |
Earnings (TTM) | -€9.43m |
Revenue (TTM) | €11.63m |
0.2x
P/S Ratio-0.2x
P/E RatioIs M5B0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
M5B0 income statement (TTM) | |
---|---|
Revenue | CA$17.32m |
Cost of Revenue | CA$13.77m |
Gross Profit | CA$3.55m |
Other Expenses | CA$17.60m |
Earnings | -CA$14.05m |
Last Reported Earnings
May 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.39 |
Gross Margin | 20.48% |
Net Profit Margin | -81.13% |
Debt/Equity Ratio | 0% |
How did M5B0 perform over the long term?
See historical performance and comparison